<DOC>
	<DOC>NCT00000348</DOC>
	<brief_summary>The purpose of this study is to evaluate safety issues pertaining to dihydrexidine (DHX), to cocaine, and to its interaction, and to determine how pretreatment with DHX modifies the subjective as well as physiological effects of cocaine infusion.</brief_summary>
	<brief_title>Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Dihydrexidine</mesh_term>
	<criteria>M/F, ages 2150. Meet DSMIV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent. Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>